Time trends and age-period-cohort analyses on incidence rates of thyroid cancer in Shanghai and Hong Kong

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Xie, Shao Hua ^a   Chen, Juan ^b   Zhang, Bo ^c,d   Wang, Feng ^c   Li, Shan Shan ^a   Xie, Chang Hui ^a   Tse, Lap Ah ^c   Cheng, Jin Quan ^a  

^a SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b Shenzhen Institute of Occupational Disease Treatment and Prevention   (China)

^c and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^d SUN YAT SEN UNIVERSITY   (China)

Author keywords

Age period cohort analysis; Etiology; Incidence; Thyroid cancer; Time trend

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CHILD; CHINA; CHINESE; COHORT ANALYSIS; ENVIRONMENTAL EXPOSURE; FEMALE; HONG KONG; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POPULATION RESEARCH; SCHOOL CHILD; SEX DIFFERENCE; SEX RATIO; THYROID CANCER; TREND STUDY; YOUNG ADULT; INCIDENCE; THYROID NEOPLASMS;

AGE FACTORS; CHINA; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; SEX FACTORS; THYROID NEOPLASMS;

EID: 84924707776     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-975     Document Type: Article

References (36)

1. Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE, Devesa SS: Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev 2009, 18:784-791. 10.1158/1055-9965.EPI-08-0960.
2. Finlayson A, Barnes I, Sayeed S, McIver B, Beral V, Ali R: Incidence of thyroid cancer in England by ethnic group, 2001-2007. Br J Cancer 2014, 110:1322-1327. 10.1038/bjc.2014.4.
3. La Vecchia C, Malvezzi M, Bosetti C, Garavello W, Bertuccio P, Levi F, Negri E: Thyroid cancer mortality and incidence: A global overview. Int J Cancer 2014. [Epub ahead of print] doi:10.1002/ijc.29251.
4. Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R: Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol 2013, 2013:965212.
5. Vigneri R, Malandrino P, Vigneri P: The changing epidemiology of thyroid cancer: why is incidence increasing? Curr Opin Oncol 2014. [Epub ahead of print] doi:10.1097/CCO.0000000000000148.
6. Wang Y, Wang W: Increasing incidence of thyroid cancer in Shanghai, China, 1983-2007. Asia Pac J Public Health 2012. [Epub ahead of print] doi:10.1177/1010539512436874.
7. Du LB, Li HZ, Wang XH, Zhu C, Liu QM, Li QL, Li XQ, Shen YZ, Zhang XP, Ying JW, Yu CD, Mao WM: Analysis of cancer incidence in Zhejiang cancer registry in China during 2000 to 2009. Asian Pac J Cancer Prev 2014, 15:5839-5843. 10.7314/APJCP.2014.15.14.5839.
8. Xie WC, Chan MH, Mak KC, Chan WT, He M: Trends in the incidence of 15 common cancers in Hong Kong, 1983-2008. Asian Pac J Cancer Prev 2012, 13:3911-3916. 10.7314/APJCP.2012.13.8.3911.
9. Hong Kong Cancer Registry: Cancer Statistics Query System (CanSQS). In Book Cancer Statistics Query System (CanSQS). City: Hong Kong Cancer Registry; Available at http://www3.ha.org.hk/cancereg/e_a1b.asp [Accessed on Oct 20 2014]
10. Li N, Du XL, Reitzel LR, Xu L, Sturgis EM: Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980-2008. Thyroid 2013, 23:103-110. 10.1089/thy.2012.0392.
11. Wartofsky L: Increasing world incidence of thyroid cancer: increased detection or higher radiation exposure? Hormones (Athens) 2010, 9:103-108. 10.14310/horm.2002.1260.
12. Rego-Iraeta A, Perez-Mendez LF, Mantinan B, Garcia-Mayor RV: Time trends for thyroid cancer in northwestern Spain: true rise in the incidence of micro and larger forms of papillary thyroid carcinoma. Thyroid 2009, 19:333-340. 10.1089/thy.2008.0210.
13. Rosenberg PS, Anderson WF: Age-period-cohort models in cancer surveillance research: ready for prime time? Cancer Epidemiol Biomarkers Prev 2011, 20:1263-1268. 10.1158/1055-9965.EPI-11-0421.
14. Robertson C, Boyle P: Age-period-cohort analysis of chronic disease rates. I: Modelling approach. Stat Med 1998, 17:1305-1323. 10.1002/(SICI)1097-0258(19980630)17:12<1305::AID-SIM853>3.0.CO;2-W.
15. Rosenberg PS, Check DP, Anderson WF: A web tool for age-period-cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol Biomarkers Prev 2014. [Epub ahead of print] doi:10.1158/1055-9965.EPI-1114-0300.
16. Kim HJ, Fay MP, Feuer EJ, Midthune DN: Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000, 19:335-351. 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z.
17. Dal Maso L, Bosetti C, La Vecchia C, Franceschi S: Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control 2009, 20:75-86. 10.1007/s10552-008-9219-5.
18. Marcello MA, Malandrino P, Almeida JF, Martins MB, Cunha LL, Bufalo NE, Pellegriti G, Ward LS: The influence of the environment on the development of thyroid tumors: a new appraisal. Endocr Relat Cancer 2014, 21:T235-T254. 10.1530/ERC-14-0131.
19. Yi Y, Zheng J, Zhuo W, Gao L: Trends in radiation exposure from clinical nuclear medicine procedures in Shanghai, China. Nucl Med Commun 2012, 33:331-336. 10.1097/MNM.0b013e32834f2a28.
20. HKCSD: Thematic Household Survey Report No. 41. Knowledge, Attitude and Practice of Medical Checkup. In Book Thematic Household Survey Report No. 41. Knowledge, Attitude and Practice of Medical Checkup. City: Hong Kong Census and Statistics Department; 2009:160-185.
21. Derwahl M, Nicula D: Estrogen and its role in thyroid cancer. Endocr Relat Cancer 2014, 21:T273-T283. 10.1530/ERC-14-0053.
22. Manole D, Schildknecht B, Gosnell B, Adams E, Derwahl M: Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. J Clin Endocrinol Metab 2001, 86:1072-1077.
23. Zeng Q, Chen GG, Vlantis AC, van Hasselt CA: Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor-ERK pathway. Cell Prolif 2007, 40:921-935. 10.1111/j.1365-2184.2007.00471.x.
24. Li LX, Chen L, Meng XZ, Chen BH, Chen SQ, Zhao Y, Zhao LF, Liang Y, Zhang YH: Exposure levels of environmental endocrine disruptors in mother-newborn pairs in China and their placental transfer characteristics. PLoS One 2013, 8:e62526. 10.1371/journal.pone.0062526.
25. Wan HT, Leung PY, Zhao YG, Wei X, Wong MH, Wong CK: Blood plasma concentrations of endocrine disrupting chemicals in Hong Kong populations. J Hazard Mater 2013, 261:763-769.
26. Truong T, Baron-Dubourdieu D, Rougier Y, Guenel P: Role of dietary iodine and cruciferous vegetables in thyroid cancer: a countrywide case-control study in New Caledonia. Cancer Causes Control 2010, 21:1183-1192. 10.1007/s10552-010-9545-2.
27. Kolonel LN, Hankin JH, Wilkens LR, Fukunaga FH, Hinds MW: An epidemiologic study of thyroid cancer in Hawaii. Cancer Causes Control 1990, 1:223-234. 10.1007/BF00117474.
28. Horn-Ross PL, Morris JS, Lee M, West DW, Whittemore AS, McDougall IR, Nowels K, Stewart SL, Spate VL, Shiau AC, Krone MR: Iodine and thyroid cancer risk among women in a multiethnic population: the Bay Area Thyroid Cancer Study. Cancer Epidemiol Biomarkers Prev 2001, 10:979-985.
29. Clero E, Doyon F, Chungue V, Rachedi F, Boissin JL, Sebbag J, Shan L, Bost-Bezeaud F, Petitdidier P, Dewailly E, Rubino C, de Vathaire F: Dietary iodine and thyroid cancer risk in French Polynesia: a case-control study. Thyroid 2012, 22:422-429. 10.1089/thy.2011.0173.
30. Wu Y, Li X, Chang S, Liu L, Zou S, Hipgrave DB: Variable iodine intake persists in the context of universal salt iodization in China. J Nutr 2012, 142:1728-1734. 10.3945/jn.112.157982.
31. Choi SW, Ryu SY, Han MA, Park J: The association between the socioeconomic status and thyroid cancer prevalence; based on the Korean National Health and Nutrition Examination Survey 2010-2011. J Korean Med Sci 2013, 28:1734-1740. 10.3346/jkms.2013.28.12.1734.
32. Sprague BL, Warren Andersen S, Trentham-Dietz A: Thyroid cancer incidence and socioeconomic indicators of health care access. Cancer Causes Control 2008, 19:585-593. 10.1007/s10552-008-9122-0.
33. Marcello MA, Cunha LL, Batista FA, Ward LS: Obesity and thyroid cancer. Endocr Relat Cancer 2014, 21:T255-T271. 10.1530/ERC-14-0070.
34. Miller MD, Crofton KM, Rice DC, Zoeller RT: Thyroid-disrupting chemicals: interpreting upstream biomarkers of adverse outcomes. Environ Health Perspect 2009, 117:1033-1041. 10.1289/ehp.0800247.
35. Davies L, Welch HG: Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006, 295:2164-2167. 10.1001/jama.295.18.2164.
36. Aschebrook-Kilfoy B, Ward MH, Sabra MM, Devesa SS: Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid 2011, 21:125-134. 10.1089/thy.2010.0021.